Lipid Nanovectors to Deliver RNA Oligonucleotides in Cancer
The growing knowledge on the mechanisms of gene silencing and gene regulation by non-coding RNAs (ncRNA), mainly small interfering RNA (siRNA) and microRNA (miRNA), is providing a significant boost to the development of new therapeutic strategies for the treatment of cancer. However, the design of R...
Main Authors: | Virginia Campani, Giuseppina Salzano, Sara Lusa, Giuseppe De Rosa |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-07-01
|
Series: | Nanomaterials |
Subjects: | |
Online Access: | http://www.mdpi.com/2079-4991/6/7/131 |
Similar Items
-
Immunogenicity Testing of Lipidoids In Vitro and In Silico: Modulating Lipidoid-Mediated TLR4 Activation by Nanoparticle Design
by: Anne Marit de Groot, et al.
Published: (2018-06-01) -
Tumor-targeted Chlorotoxin-coupled Nanoparticles for Nucleic Acid Delivery to Glioblastoma Cells: A Promising System for Glioblastoma Treatment
by: Pedro M Costa, et al.
Published: (2013-01-01) -
Lysosomal Storage Disease-Associated Neuropathy: Targeting Stable Nucleic Acid Lipid Particle (SNALP)-Formulated siRNAs to the Brain as a Therapeutic Approach
by: Maria Francisca Coutinho, et al.
Published: (2020-08-01) -
Сationic liposomes as delivery systems for nucleic acids
by: A. A. Mikheev, et al.
Published: (2020-03-01) -
Lipid Nanoparticles as Delivery Systems for RNA-Based Vaccines
by: Basmah N. Aldosari, et al.
Published: (2021-02-01)